Skip to main content
Erschienen in: Heart and Vessels 1/2023

13.07.2022 | Original Article

Prognostic impact of atrial fibrillation on the outcomes of peripheral artery disease according to preoperative symptoms for endovascular revascularization

verfasst von: Sadahiro Hijikata, Tetsuo Yamaguchi, Daisuke Ueshima, Tomoyuki Umemoto, Atsushi Mizuno, Akihiro Matsui, Nobuhito Kaneko, Shunsuke Ozaki, Tatsuki Doijiri, Kentaro Jujo, Takahide Kodama, Michiaki Higashitani

Erschienen in: Heart and Vessels | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Peripheral artery disease (PAD) and atrial fibrillation (AF) are associated with major cardiovascular and cerebrovascular events (MACCE). However, outcomes stratified according to the preoperative symptoms of PAD in patients with AF have not been sufficiently investigated. This was a retrospective study of prospectively collected data pertaining to 2237 patients (1179 patients with intermittent claudication [IC] and 1058 patients with critical limb-threatening ischemia [CLTI]) who underwent endovascular therapy at 34 hospitals between August 2014 and August 2016. AF was present in 91 (7.7%) patients with IC and 150 (14.2%) patients with CLTI. In the CLTI group, patients with AF had a higher event rate of MACCE and all-cause death than those without AF (1-year rates of freedom from MACCE: 0.66 and 0.81 in patients with and without AF, respectively, p < 0.001). In contrast, in the IC group, there was no statistically significant difference in the rates of MACCE between patients with and without AF. In the Cox multivariate analysis, AF was a significant predictor of MACCE in patients with CLTI but not in patients with IC, even after adjusting for covariates. The impact of AF on the outcome of patients with PAD was greater in those with CLTI. Further studies are needed to clarify the possible mechanisms underlying these differences.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Roth GA, Mensah GA, Johnson CO, Addolorato G, AmmiratiBaddour ELM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, KassebaumKoroshetz NW, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de OG, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, StarkSundström BJ, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76:2982–3021CrossRef Roth GA, Mensah GA, Johnson CO, Addolorato G, AmmiratiBaddour ELM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, KassebaumKoroshetz NW, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de OG, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, StarkSundström BJ, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V (2020) Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol 76:2982–3021CrossRef
2.
Zurück zum Zitat Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517–538CrossRef Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517–538CrossRef
3.
Zurück zum Zitat Fontaine R, Kim M, Kieny R (1954) Surgical treatment of peripheral circulation disorders. Helv Chir Acta 21:499–533 Fontaine R, Kim M, Kieny R (1954) Surgical treatment of peripheral circulation disorders. Helv Chir Acta 21:499–533
4.
Zurück zum Zitat Higashitani M, Uemura Y, Mizuno A, Utsunomiya M, Yamaguchi T, Matsui A, Ozaki S, Tobita K, Tosaka A, Oida A, Suzuki K, Kodama T, Jujo K, Doijiri T, Takahashi Y, Matsuno S, Kaneko N, Moriguchi A, Kishi S, Anzai H, Investigators T-C (2018) Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease-short-term results of the toma-code registry. Circ J 82:1917–1925CrossRef Higashitani M, Uemura Y, Mizuno A, Utsunomiya M, Yamaguchi T, Matsui A, Ozaki S, Tobita K, Tosaka A, Oida A, Suzuki K, Kodama T, Jujo K, Doijiri T, Takahashi Y, Matsuno S, Kaneko N, Moriguchi A, Kishi S, Anzai H, Investigators T-C (2018) Cardiovascular outcome and mortality in patients undergoing endovascular treatment for symptomatic peripheral artery disease-short-term results of the toma-code registry. Circ J 82:1917–1925CrossRef
5.
Zurück zum Zitat Wasmer K, Unrath M, Köbe J, Malyar NM, Freisinger E, Meyborg M, Breithardt G, Eckardt L, Reinecke H (2015) Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease. Int J Cardiol 199:223–228CrossRef Wasmer K, Unrath M, Köbe J, Malyar NM, Freisinger E, Meyborg M, Breithardt G, Eckardt L, Reinecke H (2015) Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease. Int J Cardiol 199:223–228CrossRef
6.
Zurück zum Zitat Vrsalović M, Presečki AV (2017) Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: a meta-analysis of prospective studies. Clin Cardiol 40:1231–1235CrossRef Vrsalović M, Presečki AV (2017) Atrial fibrillation and risk of cardiovascular events and mortality in patients with symptomatic peripheral artery disease: a meta-analysis of prospective studies. Clin Cardiol 40:1231–1235CrossRef
7.
Zurück zum Zitat Olesen JB, Gislason GH, Torp-Pedersen C, Lip G (2012) Atrial fibrillation and vascular disease—a bad combination. Clin Cardiol 35:15–20CrossRef Olesen JB, Gislason GH, Torp-Pedersen C, Lip G (2012) Atrial fibrillation and vascular disease—a bad combination. Clin Cardiol 35:15–20CrossRef
8.
Zurück zum Zitat Chang CJ, Chen YT, Liu CS, Lin WY, Lin CL, Lin MC, Kao CH (2016) Atrial fibrillation increases the risk of peripheral arterial disease with relative complications and mortality: a population-based cohort study. Medicine (Baltimore) 95(9):e3002CrossRef Chang CJ, Chen YT, Liu CS, Lin WY, Lin CL, Lin MC, Kao CH (2016) Atrial fibrillation increases the risk of peripheral arterial disease with relative complications and mortality: a population-based cohort study. Medicine (Baltimore) 95(9):e3002CrossRef
9.
Zurück zum Zitat Taylor SM, Cull DL, Kalbaugh CA, Senter HF, Langan EM, Carsten CG, York JW, Snyder BA, Gray BH, Androes MP, Blackhurst DW (2009) Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2240 limb revascularizations. J Am Coll Surg 208:770–780CrossRef Taylor SM, Cull DL, Kalbaugh CA, Senter HF, Langan EM, Carsten CG, York JW, Snyder BA, Gray BH, Androes MP, Blackhurst DW (2009) Comparison of interventional outcomes according to preoperative indication: a single center analysis of 2240 limb revascularizations. J Am Coll Surg 208:770–780CrossRef
10.
Zurück zum Zitat Vrsalović M, Vučur K, Presečki AV, Fabijanić D, Milošević M (2017) Impact of diabetes on mortality in peripheral artery disease: a meta-analysis. Clin Cardiol 40:287–291CrossRef Vrsalović M, Vučur K, Presečki AV, Fabijanić D, Milošević M (2017) Impact of diabetes on mortality in peripheral artery disease: a meta-analysis. Clin Cardiol 40:287–291CrossRef
11.
Zurück zum Zitat Vrsalović M, Presečki AV, Aboyans V (2022) Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: a systematic review and meta-analysis of adjusted observational studies. Clin Cardiol 45:198–204CrossRef Vrsalović M, Presečki AV, Aboyans V (2022) Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: a systematic review and meta-analysis of adjusted observational studies. Clin Cardiol 45:198–204CrossRef
12.
Zurück zum Zitat Wieczór R, Kulwas A, Rość D (2020) Implications of hemostasis disorders in patients with critical limb ischemia-an in-depth comparison of selected factors. J Clin Med 9:659CrossRef Wieczór R, Kulwas A, Rość D (2020) Implications of hemostasis disorders in patients with critical limb ischemia-an in-depth comparison of selected factors. J Clin Med 9:659CrossRef
13.
Zurück zum Zitat Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, Min J, Torii S, Poojary P, Anand SS, Bax JJ, Yusuf S, Virmani R, Narula J (2018) Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol 72:2152–2163CrossRef Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, Min J, Torii S, Poojary P, Anand SS, Bax JJ, Yusuf S, Virmani R, Narula J (2018) Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol 72:2152–2163CrossRef
14.
Zurück zum Zitat Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G (2007) Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120:193–197CrossRef Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G (2007) Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120:193–197CrossRef
15.
Zurück zum Zitat Akar JG, Jeske W, Wilber DJ (2008) Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 51:1790–1793CrossRef Akar JG, Jeske W, Wilber DJ (2008) Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 51:1790–1793CrossRef
16.
Zurück zum Zitat Yamaguchi T, Ueshima D, Utsunomiya M, Matsui A, Miyazaki T, Matsumoto M, Shimura T, Murata N, Komatsu Y, Tobita K, Fujimoto Y, Kodama T, Suzuki K, Anzai H, Jujo K, Higashitani M (2021) Optimal cut-off value of preprocedual geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease. J Cardiol 77:109–115CrossRef Yamaguchi T, Ueshima D, Utsunomiya M, Matsui A, Miyazaki T, Matsumoto M, Shimura T, Murata N, Komatsu Y, Tobita K, Fujimoto Y, Kodama T, Suzuki K, Anzai H, Jujo K, Higashitani M (2021) Optimal cut-off value of preprocedual geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease. J Cardiol 77:109–115CrossRef
17.
Zurück zum Zitat Tsay C, Luo J, Zhang Y, Attaran R, Dardik A, Ochoa Chaar CI (2020) Perioperative outcomes of lower extremity revascularization for rest pain and tissue loss. Ann Vasc Surg 66:493–501CrossRef Tsay C, Luo J, Zhang Y, Attaran R, Dardik A, Ochoa Chaar CI (2020) Perioperative outcomes of lower extremity revascularization for rest pain and tissue loss. Ann Vasc Surg 66:493–501CrossRef
18.
Zurück zum Zitat Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S (2018) Major adverse limb events and mortality in patients with peripheral artery disease: the compass trial. J Am Coll Cardiol 71:2306–2315CrossRef Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V, Abola MT, Branch KRH, Keltai K, Bhatt DL, Verhamme P, Fox KAA, Cook-Bruns N, Lanius V, Connolly SJ, Yusuf S (2018) Major adverse limb events and mortality in patients with peripheral artery disease: the compass trial. J Am Coll Cardiol 71:2306–2315CrossRef
19.
Zurück zum Zitat Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, Mátyás L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR (2020) Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 382:1994–2004CrossRef Bonaca MP, Bauersachs RM, Anand SS, Debus ES, Nehler MR, Patel MR, Fanelli F, Capell WH, Diao L, Jaeger N, Hess CN, Pap AF, Kittelson JM, Gudz I, Mátyás L, Krievins DK, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Berkowitz SD, Hiatt WR (2020) Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med 382:1994–2004CrossRef
20.
Zurück zum Zitat Lomashvili KA, Wa X, Wallin R, O’Neill WC (2011) Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem 286:28715–28722CrossRef Lomashvili KA, Wa X, Wallin R, O’Neill WC (2011) Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem 286:28715–28722CrossRef
21.
Zurück zum Zitat Lee HF, Chan YH, Li PR, Liu JR, Chao TF, Wu LS, Chang SH, Yeh YH, Kuo CT, See LC, Lip GYH (2021) Oral anticoagulants and antiplatelet agents in patients with atrial fibrillation and concomitant critical limb ischemia: a nationwide cohort study. Can J Cardiol 37:113–121CrossRef Lee HF, Chan YH, Li PR, Liu JR, Chao TF, Wu LS, Chang SH, Yeh YH, Kuo CT, See LC, Lip GYH (2021) Oral anticoagulants and antiplatelet agents in patients with atrial fibrillation and concomitant critical limb ischemia: a nationwide cohort study. Can J Cardiol 37:113–121CrossRef
Metadaten
Titel
Prognostic impact of atrial fibrillation on the outcomes of peripheral artery disease according to preoperative symptoms for endovascular revascularization
verfasst von
Sadahiro Hijikata
Tetsuo Yamaguchi
Daisuke Ueshima
Tomoyuki Umemoto
Atsushi Mizuno
Akihiro Matsui
Nobuhito Kaneko
Shunsuke Ozaki
Tatsuki Doijiri
Kentaro Jujo
Takahide Kodama
Michiaki Higashitani
Publikationsdatum
13.07.2022
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 1/2023
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-022-02134-8

Weitere Artikel der Ausgabe 1/2023

Heart and Vessels 1/2023 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.